Literature DB >> 1636680

Interferon-gamma is an inducer of plasminogen activator inhibitor type 1 in human orbital fibroblasts.

T J Smith1, A Ahmed, M G Hogg, P J Higgins.   

Abstract

Expression of plasminogen activator inhibitor type 1 (PAI-1), an important determinant of the pericellular proteolytic environment, was assessed in cultured human orbital and dermal fibroblasts. Bidimensional electrophoretic separation of total cellular [35S]methionine-labeled proteins revealed multiple isoforms of the 50-kDa PAI-1 protein (isoelectric point range 5.6-6.3) expressed in dermal strains but not in orbital cultures. The addition of human recombinant interferon-gamma (100 U/ml) to the media for 48 h resulted in a marked induction of PAI-1 in the orbital cultures (greater than 50-fold above baseline), whereas the expression in dermal cultures was either attenuated or induced modestly (5-fold). The identity of the 50-kDa PAI-1 was verified by immunoprecipitation of secreted proteins. Indirect immunofluorescence localized PAI-1 to aggregates at the ventral undersurface of the monolayer. Interferon-gamma induced several other proteins in cultured cells. The observation that untreated orbital fibroblasts do not express detectable cell-associated PAI-1 suggests that the pericellular proteolytic environment of these cells is regulated ordinarily by other factors. The economy of the extracellular matrix of orbital connective tissue may be particularly susceptible to the influence of inflammatory cytokines such as interferon-gamma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1636680     DOI: 10.1152/ajpcell.1992.263.1.C24

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Novel aspects of orbital fibroblast pathology.

Authors:  T J Smith
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

2.  Leukoregulin induction of protein expression in human orbital fibroblasts: evidence for anatomical site-restricted cytokine-target cell interactions.

Authors:  D A Young; C H Evans; T J Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

Review 3.  Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation.

Authors:  R S Smith; T J Smith; T M Blieden; R P Phipps
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 4.  Insights into the role of fibroblasts in human autoimmune diseases.

Authors:  T J Smith
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

5.  Cytokines are both villains and potential therapeutic targets in thyroid-associated ophthalmopathy: From bench to bedside.

Authors:  Fatemeh Rajaii; Allison N McCoy; Terry J Smith
Journal:  Expert Rev Ophthalmol       Date:  2014-06

6.  Prostaglandin E2 elicits a morphological change in cultured orbital fibroblasts from patients with Graves ophthalmopathy.

Authors:  T J Smith; H S Wang; M G Hogg; R C Henrikson; C R Keese; I Giaever
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.

Authors:  Shanli Tsui; Vibha Naik; Neil Hoa; Catherine J Hwang; Nikoo F Afifiyan; Amiya Sinha Hikim; Andrew G Gianoukakis; Raymond S Douglas; Terry J Smith
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

8.  Ultrastructure of cultured human orbital fibroblasts.

Authors:  R C Henrikson; T J Smith
Journal:  Cell Tissue Res       Date:  1994-12       Impact factor: 5.249

9.  Cell-shape-dependent modulation of p52(PAI-1) gene expression involves a secondary response pathway.

Authors:  P J Higgins; L Staiano-Coico; M P Ryan
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.